Browse Items (1 total)

The combination of aspirin, a thienopyridine derivative, and a glycoprotein IIb/IIIa receptor inhibitor has become standard therapy for patients undergoing percutaneous coronary intervention (PCI). Recent studies have shown an increased incidence of…
Output Formats

atom, dcmes-xml, json, omeka-xml, rss2